This compound is a brominated quinolinone derivative used as a pharmaceutical intermediate. It features an amide group, an aromatic ring, an ether linkage, and a halogen substituent, with moderate lipophilicity and a polar surface area of 38.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 129722-34-5
1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
pharmaceutical impurity
7-(4-chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone
pharmaceutical impurity reference standard
2-Chloro-4-(1H-pyrazol-3-yl)benzonitrile
pharmaceutical intermediate
(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile
Pharmaceutical intermediate for darolutamide
3-acetyl-1H-pyrazole-5-carboxylic acid
pharmaceutical intermediate
Di-tert-butyl (2-oxopropane-1,3-diyl)dicarbamate
synthetic intermediate for midazolam impurities
7-Methoxy-3,4-dihydroquinolin-2(1H)-one
Pharmaceutical intermediate
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone
pharmaceutical intermediate
7-(4-bromobutoxy)-3,4-dihydro-1H-quinolin-2-one
URHLNHVYMNBPEO-UHFFFAOYSA-N
C1CC(=O)NC2=C1C=CC(=C2)OCCCCBr